And I’m not even talking about greenies or horse liniment or whatever old school product that enhanced performance even if people today want to act like it didn’t. I’m talking about steroids or HGH or PEDs in that general category. We like to pretend that there isn’t anyone who did that before Jose Canseco, but that’s almost certainly false.
Evidence? For one thing there was Thomas Boswell in Ken Burns’ “Baseball” documentary update “The Tenth Inning,” who said that he personally witnessed a current Hall of Famer take a PED-laden shake:
“There was another player now in the Hall of Fame who literally stood with me and mixed something and I said “What’s that?” and he said “it’s a Jose Canseco milkshake”. And that year that Hall of Famer hit more home runs than ever hit any other year. So it wasn’t just Canseco, and so one of the reasons that I thought that it was an important subject was that it was spreading. It was already spreading by 1988.”
Everyone forgets that and Boswell tends to keep pretty silent about that come Hall of Fame voting time in December.
Then, just last night came this interesting tidbit from Patty Blyleven, first wife of Hall of Famer Bert Blyleven, from Ross Newhan’s Facebook page just last night:
No, I do not consider Patty Blyleven to be an authoritative source on such matters. She may be passing things along third hand for all we know. But it’s naive in the extreme to think that the first ballplayer to ever take PEDs and then try to enter the Hall of Fame was Mark McGwire or someone of his era.
Yankees starter Luis Severino and Phillies starter Aaron Nola both signed contract extensions within the last week. Severino agreed to a four-year, $40 million contract with a 2023 club option. Nola inked a four-year, $45 million deal with a 2023 club option.
While the deals both represented significant raises and longer-term financial security for the right-handed duo, some feel like the players are selling themselves short. It has become a more common practice for players to agree to these types of deals in part due to how stagnant free agency has become. Get the money while you can.
Mets starter Noah Syndergaard is in a similar situation as Severino and Nola were. He and the Mets avoided arbitration last month, agreeing on a $6 million salary for the 2019 season. He has two more years of arbitration eligibility left. A contract extension with the Mets would presumably cover both of those years plus two or three years of what would be free agent years. As Tim Britton of The Athletic reports, however, Syndergaard plans to test free agency when the time comes.
Syndergaard said, “I trust my ability and the talent that I have. So I feel like I’m going to bet (on) myself in free agency and not do what they did. But if it’s fair for both sides and they approach me on it, then maybe we can talk.” He clarified that he would be open to a conversation about an extension, but the Mets thus far haven’t approached him about it. In his words, “There’s been no traction.”
Syndergaard, 26, has been one of baseball’s better starters since debuting in 2015. He owns a career 2.93 ERA with 573 strikeouts and 116 walks in 518 1/3 innings. Among pitchers to have logged at least 400 innings since 2015 and post a lower ERA are Clayton Kershaw (2.22), Jacob deGrom (2.66) and Max Scherzer (2.71). Syndergaard made only seven starts in 2017 yet still ranks seventh among pitchers in total strikeouts since 2015.
If Sydergaard doesn’t end up signing an extension, he will be entering free agency after the 2021 season. The collective bargaining agreement expires in December 2021 and a new one will likely be agreed upon around that time. Syndergaard will hopefully have better prospects entering free agency then than players do now.